Fig. 4From: circPSD3 is a promising inhibitor of uPA system to inhibit vascular invasion and metastasis in hepatocellular carcinomacircPSD3 promotes the metastasis and vascular invasion of HCC cells in vivo. (A) Representative images and quantification of H&E staining of lung metastatic nodules of nude mice injected with circPSD3-overexpressing or control HCC-LM9 cells via the tail vein. Scale bar, upper = 1000 μm; lower = 400 μm. (B) Representative images and quantification of H&E staining of intrahepatic metastatic nodules in the circPSD3 overexpression and control groups. Scale bar, upper = 300 μm; lower = 100 μm. (C) H&E-stained serial liver sections showing intrahepatic vascular invasion in the circPSD3 overexpression and control groups. Scale bar, upper = 400 μm; lower = 30 μm. (D–F) Representative images and quantification of H&E staining of lung metastatic nodules, intrahepatic metastatic nodules, and intrahepatic vascular invasion in the circPSD3 knockdown and control groups. Each group contained 5 mice. Data are shown as the mean ± SD. Statistical analyses were performed using unpaired Student’s t-tests (**p < 0.01; ***p < 0.001). circPSD3, circRNA pleckstrin and Sect. 7 domain containing 3; HCC, hepatocellular carcinoma; H&E, haematoxylin and eosinBack to article page